BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38081435)

  • 1. Neuroimmune activation and increased brain aging in chronic pain patients after the COVID-19 pandemic onset.
    Brusaferri L; Alshelh Z; Schnieders JH; Sandström A; Mohammadian M; Morrissey EJ; Kim M; Chane CA; Grmek GC; Murphy JP; Bialobrzewski J; DiPietro A; Klinke J; Zhang Y; Torrado-Carvajal A; Mercaldo N; Akeju O; Wu O; Rosen BR; Napadow V; Hadjikhani N; Loggia ML
    Brain Behav Immun; 2024 Feb; 116():259-266. PubMed ID: 38081435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain glial activation in fibromyalgia - A multi-site positron emission tomography investigation.
    Albrecht DS; Forsberg A; Sandström A; Bergan C; Kadetoff D; Protsenko E; Lampa J; Lee YC; Höglund CO; Catana C; Cervenka S; Akeju O; Lekander M; Cohen G; Halldin C; Taylor N; Kim M; Hooker JM; Edwards RR; Napadow V; Kosek E; Loggia ML
    Brain Behav Immun; 2019 Jan; 75():72-83. PubMed ID: 30223011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroimmune signatures in chronic low back pain subtypes.
    Alshelh Z; Brusaferri L; Saha A; Morrissey E; Knight P; Kim M; Zhang Y; Hooker JM; Albrecht D; Torrado-Carvajal A; Placzek MS; Akeju O; Price J; Edwards RR; Lee J; Sclocco R; Catana C; Napadow V; Loggia ML
    Brain; 2022 Apr; 145(3):1098-1110. PubMed ID: 34528069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pandemic brain: Neuroinflammation in non-infected individuals during the COVID-19 pandemic.
    Brusaferri L; Alshelh Z; Martins D; Kim M; Weerasekera A; Housman H; Morrissey EJ; Knight PC; Castro-Blanco KA; Albrecht DS; Tseng CE; Zürcher NR; Ratai EM; Akeju O; Makary MM; Catana C; Mercaldo ND; Hadjikhani N; Veronese M; Turkheimer F; Rosen BR; Hooker JM; Loggia ML
    Brain Behav Immun; 2022 May; 102():89-97. PubMed ID: 35181440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroinflammation in Temporal Lobe Epilepsy Measured Using Positron Emission Tomographic Imaging of Translocator Protein.
    Gershen LD; Zanotti-Fregonara P; Dustin IH; Liow JS; Hirvonen J; Kreisl WC; Jenko KJ; Inati SK; Fujita M; Morse CL; Brouwer C; Hong JS; Pike VW; Zoghbi SS; Innis RB; Theodore WH
    JAMA Neurol; 2015 Aug; 72(8):882-8. PubMed ID: 26052981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudoreference Regions for Glial Imaging with
    Albrecht DS; Normandin MD; Shcherbinin S; Wooten DW; Schwarz AJ; Zürcher NR; Barth VN; Guehl NJ; Akeju O; Atassi N; Veronese M; Turkheimer F; Hooker JM; Loggia ML
    J Nucl Med; 2018 Jan; 59(1):107-114. PubMed ID: 28818984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neuroinflammatory component of negative affect in patients with chronic pain.
    Albrecht DS; Kim M; Akeju O; Torrado-Carvajal A; Edwards RR; Zhang Y; Bergan C; Protsenko E; Kucyi A; Wasan AD; Hooker JM; Napadow V; Loggia ML
    Mol Psychiatry; 2021 Mar; 26(3):864-874. PubMed ID: 31138890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moving Toward Multicenter Therapeutic Trials in Amyotrophic Lateral Sclerosis: Feasibility of Data Pooling Using Different Translocator Protein PET Radioligands.
    Van Weehaeghe D; Babu S; De Vocht J; Zürcher NR; Chew S; Tseng CJ; Loggia ML; Koole M; Rezaei A; Schramm G; Van Damme P; Hooker JM; Van Laere K; Atassi N
    J Nucl Med; 2020 Nov; 61(11):1621-1627. PubMed ID: 32169920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease activity in rheumatoid arthritis is inversely related to cerebral TSPO binding assessed by [
    Forsberg A; Lampa J; Estelius J; Cervenka S; Farde L; Halldin C; Lekander M; Olgart Höglund C; Kosek E
    J Neuroimmunol; 2019 Sep; 334():577000. PubMed ID: 31260948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative assessment of translocator protein (TSPO) in the non-human primate brain and clinical translation of [
    Tan Z; Haider A; Zhang S; Chen J; Wei J; Liao K; Li G; Wei H; Dong C; Ran W; Li Y; Li Y; Rong J; Li Y; Liang SH; Xu H; Wang L
    Pharmacol Res; 2023 Mar; 189():106681. PubMed ID: 36746361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does seasonal variation affect the neuroimmune system? A retrospective [
    Ibrahim W; An J; Yang Y; Cosgrove KP; Matuskey D
    Neurosci Lett; 2024 Apr; 828():137766. PubMed ID: 38583505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study protocol for a phase II, double-blind, randomised controlled trial of cannabidiol (CBD) compared with placebo for reduction of brain neuroinflammation in adults with chronic low back pain.
    Pike CK; Kim M; Schnitzer K; Mercaldo N; Edwards R; Napadow V; Zhang Y; Morrissey EJ; Alshelh Z; Evins AE; Loggia ML; Gilman JM
    BMJ Open; 2022 Sep; 12(9):e063613. PubMed ID: 36123113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebellum Can Serve As a Pseudo-Reference Region in Alzheimer Disease to Detect Neuroinflammation Measured with PET Radioligand Binding to Translocator Protein.
    Lyoo CH; Ikawa M; Liow JS; Zoghbi SS; Morse CL; Pike VW; Fujita M; Innis RB; Kreisl WC
    J Nucl Med; 2015 May; 56(5):701-6. PubMed ID: 25766898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroinflammation After COVID-19 With Persistent Depressive and Cognitive Symptoms.
    Braga J; Lepra M; Kish SJ; Rusjan PM; Nasser Z; Verhoeff N; Vasdev N; Bagby M; Boileau I; Husain MI; Kolla N; Garcia A; Chao T; Mizrahi R; Faiz K; Vieira EL; Meyer JH
    JAMA Psychiatry; 2023 Aug; 80(8):787-795. PubMed ID: 37256580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain translocator protein occupancy by ONO-2952 in healthy adults: A Phase 1 PET study using [
    Frankle WG; Narendran R; Wood AT; Suto F; Himes ML; Kobayashi M; Ohno T; Yamauchi A; Mitsui K; Duffy K; Bruce M
    Synapse; 2017 Jul; 71(7):. PubMed ID: 28245513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease.
    Kreisl WC; Lyoo CH; McGwier M; Snow J; Jenko KJ; Kimura N; Corona W; Morse CL; Zoghbi SS; Pike VW; McMahon FJ; Turner RS; Innis RB;
    Brain; 2013 Jul; 136(Pt 7):2228-38. PubMed ID: 23775979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translocator positron-emission tomography and magnetic resonance spectroscopic imaging of brain glial cell activation in multiple sclerosis.
    Datta G; Violante IR; Scott G; Zimmerman K; Santos-Ribeiro A; Rabiner EA; Gunn RN; Malik O; Ciccarelli O; Nicholas R; Matthews PM
    Mult Scler; 2017 Oct; 23(11):1469-1478. PubMed ID: 27903933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thalamic neuroinflammation as a reproducible and discriminating signature for chronic low back pain.
    Torrado-Carvajal A; Toschi N; Albrecht DS; Chang K; Akeju O; Kim M; Edwards RR; Zhang Y; Hooker JM; Duggento A; Kalpathy-Cramer J; Napadow V; Loggia ML
    Pain; 2021 Apr; 162(4):1241-1249. PubMed ID: 33065737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated imaging of [
    Ratai EM; Alshikho MJ; Zürcher NR; Loggia ML; Cebulla CL; Cernasov P; Reynolds B; Fish J; Seth R; Babu S; Paganoni S; Hooker JM; Atassi N
    Neuroimage Clin; 2018; 20():357-364. PubMed ID: 30112276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging the Influence of Red Blood Cell Docosahexaenoic Acid Status on the Expression of the 18 kDa Translocator Protein in the Brain: A [
    Tollefson S; Himes ML; Kozinski KM; Lopresti BJ; Mason NS; Hibbeln J; Muldoon MF; Narendran R
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2022 Oct; 7(10):998-1006. PubMed ID: 34607054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.